Supraspinatus Tendinitis
Conditions
Keywords
Supraspinatus tendinosis; PRP; Shoulder;
Brief summary
It was conducted a prospective study with a series of 50 patients treated with PRP one-shot injection in patient affected by Supraspinatus Tendinosis. One independent observer performed clinical and functional evaluations at T0 (recruitment), T1 (one month after the injection), T2 (three months after the last injection) and T3 (six months after the last injection). Constant Score, The Disabilites of the Arm,Shoulder and Hand Score (DASH) And Visual Analogue Scale (VAS) were administered at each evaluation.
Interventions
PROCEDUREone-shot PRP injection
A single injection of PRP (7% concentrate) ml 4 was made in the Supraspinatus tendon and in the Subacromial space under ultrasound guidance.
Sponsors
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age \> 18 years old; * Supraspinatus tendinosis detected by MRI.
Exclusion criteria
* Supraspinatus rupture; * Previous shoulder surgery; * Rotator cuff tears secondary to fracture; * Hemoglobin \<7 g/dL or Platelets \< 30,000 microL; * Active infection; * Pregnant patients; * Patients with hematologic and oncologic diseases.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Visual Analogic Scale | Day 0; Month 1; Month 3; Month 6 (after the injection) | The shoulder pain was quantified using the Visual Analogic Scale ranging from 0 (no pain) to 10 (worst imaginable pain). |
Countries
Italy
Outcome results
None listed